English

Previously submitted 13 June 2007: New incentive plan in the Lundbeck Group

Report this content 
At a board meeting held on 11 June 2007, the Supervisory Board of H.
Lundbeck A/S resolved, pursuant to the authorisation in article 4.3
of the company's articles of association, to issue warrants for up to
a nominal value of DKK 5,000,000, corresponding to 1,000,000 shares.

Members of H. Lundbeck A/S' Executive Management and Danish and
foreign executives appointed by H. Lundbeck A/S' Executive Management
who are employed by H. Lundbeck A/S or H. Lundbeck A/S' subsidiaries
are eligible to receive warrants. The above-mentioned subsidiaries
comprise Danish and foreign enterprises in which H. Lundbeck A/S
directly or indirectly holds at least 50% of the shares. The plan
will comprise about 90 employees. The plan will not comprise the
members of the company's Supervisory Board.

The Supervisory Board has determined the number of warrants that each
member of the Executive Management may subscribe:

Claus Bræstrup             53,000 warrants
Lars Bang                     40,000 warrants
Stig Løkke Pedersen     40,000 warrants

Furthermore, the Supervisory Board has determined that the new member
of the Executive Management, Mr. Anders Götzsche, CFO, may subscribe
for 40,000 warrants, provided that the CFO will accede to his
position no later than 3 September 2007.

Other Danish and foreign executives (80-90 executives) will on
average be granted approximately 9,000 warrants.
The warrants will be granted on 13 August 2007, however as regards
the CFO the day of grant will be the day of accession, if the CFO
accedes during the period from 14 August to 3 September 2007, both
days included.
Each warrant under the plan entitles the holder to subscribe 1 (one)
Lundbeck share of DKK 5 nominal value. The subscription of shares
will take place at a price per share of DKK 5 nominal value,
corresponding to the average closing price of the H. Lundbeck A/S
share on the Copenhagen Stock Exchange (all trades) on the business
days during the period from 23 July 2007 to 27 July 2007, both days
included, plus interest corresponding to 10% p.a. from 28 July 2007
until 1 August 2008 rounded down to the nearest whole number of
kroner.

The warrants can be exercised during the period from 1 August 2008 to
31 March 2011.

The market value of the warrants granted is calculated using the
Black Scholes formula and is based on a volatility of the Lundbeck
share of 29, a dividend payout ratio of 1.44 %, a risk-free interest
rate of 4.25 % and an average holding period of approximately 30
months. Applying these assumptions, the market value has been
calculated at approximately DKK 20.60 per warrant, based on a price
of the H. Lundbeck A/S share of DKK 130.
For accounting purposes, the warrants will be recognised over the
income statement at fair value (Black-Scholes) in Q3 2007.

The content of this release will have no influence on the Lundbeck
Group's financial result for 2007.

Lundbeck contacts


Investors:                  Media:

Jacob Tolstrup              Caroline Broge
Investor Relations Manager, Media Relations Manager
North America               +45 36 43 26 38
+1 201 350 0187

________________________

Stock Exchange Release No 278 - 13 June 2007

About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in
the research and development, production, marketing and sale of drugs
for the treatment of psychiatric and neurological disorders. In 2006,
the company's revenue was DKK 9.2 billion (approximately EUR 1.2
billion or USD 1.6 billion). The number of employees is approximately
5,300 globally. For further information, please visit
www.lundbeck.com

Subscribe